HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Hypopharyngeal Cancer

Hypopharyngeal cancer is a type of malignancy that originates in the hypopharynx, which is the lower part of the throat located behind the voice box (larynx). This rare form of cancer is often diagnosed at an advanced stage due to the lack of early symptoms, making it challenging to detect in its initial phases. The primary risk factors for hypopharyngeal cancer include tobacco and alcohol use, with individuals who engage in both behaviors facing a significantly higher risk. Persistent irritation from these substances can lead to the development of cancerous cells in the hypopharynx. Symptoms of hypopharyngeal cancer may include difficulty swallowing (dysphagia), a persistent sore throat, ear pain, and noticeable weight loss. As the disease progresses, individuals may experience changes in their voice and the development of lumps or swelling in the neck. Diagnosis typically involves a thorough examination of the throat, imaging studies such as CT scans and MRIs, and a biopsy to confirm the presence of cancerous cells. Treatment options depend on the stage of the cancer but often involve a combination of surgery, radiation therapy, and chemotherapy. Prognosis for hypopharyngeal cancer is generally less favorable than for cancers in other parts of the throat. Regular medical check-ups, especially for individuals with risk factors, can aid in the early identification of any potential issues in the hypopharynx, allowing for timely intervention. As with many cancers, lifestyle modifications such as quitting smoking and reducing alcohol consumption can contribute to prevention.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp